144 related articles for article (PubMed ID: 32249801)
1. CXXC5 as an unmethylated CpG dinucleotide binding protein contributes to estrogen-mediated cellular proliferation.
Ayaz G; Razizadeh N; Yaşar P; Kars G; Kahraman DC; Saatci Ö; Şahin Ö; Çetin-Atalay R; Muyan M
Sci Rep; 2020 Apr; 10(1):5971. PubMed ID: 32249801
[TBL] [Abstract][Full Text] [Related]
2. Estradiol-Estrogen Receptor α Mediates the Expression of the CXXC5 Gene through the Estrogen Response Element-Dependent Signaling Pathway.
Yaşar P; Ayaz G; Muyan M
Sci Rep; 2016 Nov; 6():37808. PubMed ID: 27886276
[TBL] [Abstract][Full Text] [Related]
3. A prelude to the proximity interaction mapping of CXXC5.
Ayaz G; Turan G; Olgun ÇE; Kars G; Karakaya B; Yavuz K; Demiralay ÖD; Can T; Muyan M; Yaşar P
Sci Rep; 2021 Sep; 11(1):17587. PubMed ID: 34475492
[TBL] [Abstract][Full Text] [Related]
4. A CpG island promoter drives the CXXC5 gene expression.
Yaşar P; Kars G; Yavuz K; Ayaz G; Oğuztüzün Ç; Bilgen E; Suvacı Z; Çetinkol ÖP; Can T; Muyan M
Sci Rep; 2021 Aug; 11(1):15655. PubMed ID: 34341443
[TBL] [Abstract][Full Text] [Related]
5. CXXC5: A novel regulator and coordinator of TGF-β, BMP and Wnt signaling.
Xiong X; Tu S; Wang J; Luo S; Yan X
J Cell Mol Med; 2019 Feb; 23(2):740-749. PubMed ID: 30479059
[TBL] [Abstract][Full Text] [Related]
6. Modulation of Estrogen Response Element-Driven Gene Expressions and Cellular Proliferation with Polar Directions by Designer Transcription Regulators.
Muyan M; Güpür G; Yaşar P; Ayaz G; User SD; Kazan HH; Huang Y
PLoS One; 2015; 10(8):e0136423. PubMed ID: 26295471
[TBL] [Abstract][Full Text] [Related]
7. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters.
Kininis M; Chen BS; Diehl AG; Isaacs GD; Zhang T; Siepel AC; Clark AG; Kraus WL
Mol Cell Biol; 2007 Jul; 27(14):5090-104. PubMed ID: 17515612
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells.
Albanito L; Madeo A; Lappano R; Vivacqua A; Rago V; Carpino A; Oprea TI; Prossnitz ER; Musti AM; Andò S; Maggiolini M
Cancer Res; 2007 Feb; 67(4):1859-66. PubMed ID: 17308128
[TBL] [Abstract][Full Text] [Related]
9. Zinc-finger protein CXXC5 promotes breast carcinogenesis by regulating the TSC1/mTOR signaling pathway.
Wang W; Zhang Z; Zhao M; Wang Y; Ge Y; Shan L
J Biol Chem; 2023 Jan; 299(1):102812. PubMed ID: 36539038
[TBL] [Abstract][Full Text] [Related]
10. Protein kinase A exhibits selective modulation of estradiol-dependent transcription in breast cancer cells that is associated with decreased ligand binding, altered estrogen receptor alpha promoter interaction, and changes in receptor phosphorylation.
Al-Dhaheri MH; Rowan BG
Mol Endocrinol; 2007 Feb; 21(2):439-56. PubMed ID: 17068199
[TBL] [Abstract][Full Text] [Related]
11. Gene regulation in an MCF-7 cell line that naturally expresses an estrogen receptor unable to directly bind DNA.
Pentecost BT; Bradley LM; Gierthy JF; Ding Y; Fasco MJ
Mol Cell Endocrinol; 2005 Jun; 238(1-2):9-25. PubMed ID: 15913882
[TBL] [Abstract][Full Text] [Related]
12. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer.
Eeckhoute J; Carroll JS; Geistlinger TR; Torres-Arzayus MI; Brown M
Genes Dev; 2006 Sep; 20(18):2513-26. PubMed ID: 16980581
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 9 agonist inhibits ERalpha-mediated transactivation by activating NF-kappaB in breast cancer cell lines.
Qiu J; Wang X; Guo X; Zhao C; Wu X; Zhang Y
Oncol Rep; 2009 Oct; 22(4):935-41. PubMed ID: 19724876
[TBL] [Abstract][Full Text] [Related]
14. Dense collagen-I matrices enhance pro-tumorigenic estrogen-prolactin crosstalk in MCF-7 and T47D breast cancer cells.
Barcus CE; Holt EC; Keely PJ; Eliceiri KW; Schuler LA
PLoS One; 2015; 10(1):e0116891. PubMed ID: 25607819
[TBL] [Abstract][Full Text] [Related]
15. OCT-4: a novel estrogen receptor-α collaborator that promotes tamoxifen resistance in breast cancer cells.
Bhatt S; Stender JD; Joshi S; Wu G; Katzenellenbogen BS
Oncogene; 2016 Nov; 35(44):5722-5734. PubMed ID: 27065334
[TBL] [Abstract][Full Text] [Related]
16. ERE-independent ERalpha target genes differentially expressed in human breast tumors.
Glidewell-Kenney C; Weiss J; Lee EJ; Pillai S; Ishikawa T; Ariazi EA; Jameson JL
Mol Cell Endocrinol; 2005 Dec; 245(1-2):53-9. PubMed ID: 16298037
[TBL] [Abstract][Full Text] [Related]
17. The estrogen receptor-interacting protein HPIP increases estrogen-responsive gene expression through activation of MAPK and AKT.
Wang X; Yang Z; Zhang H; Ding L; Li X; Zhu C; Zheng Y; Ye Q
Biochim Biophys Acta; 2008 Jun; 1783(6):1220-8. PubMed ID: 18302941
[TBL] [Abstract][Full Text] [Related]
18. Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor alpha in T47D breast cancer cells.
Chen Y; Huang K; Chen KE; Walker AM
Breast Cancer Res Treat; 2010 Apr; 120(2):369-77. PubMed ID: 19377875
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of ZBTB7A inhibits cell proliferation of breast cancer through regulating the ubiquitination of estrogen receptor alpha.
Xiao X; Shen Y; Yin L; He J; Ni X; Luo G; Chen X; Zhu W; Zhong J; Liu J; Peng X; Zu X
Life Sci; 2019 Dec; 239():117042. PubMed ID: 31715186
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells.
Zhang H; Xie X; Zhu X; Zhu J; Hao C; Lu Q; Ding L; Liu Y; Zhou L; Liu Y; Huang C; Wen C; Ye Q
J Biol Chem; 2005 Dec; 280(52):43188-97. PubMed ID: 16219765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
